M. Cruellas

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy

D. Isla, J. Pardo, A. Ramírez-Labrada, 2020, Frontiers in Oncology.

Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic Defects.

E. Jonasch, J. Balmaña, E. Hasanov, 2022, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Genetic and functional homologous repair deficiency as biomarkers for platinum sensitivity in TNBC: A case report

J. De La Torre, V. Peg, J. Balmaña, 2022, Frontiers in Oncology.

How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A Review

D. Isla, J. Pardo, E. M. Gálvez, 2021, Infection and immunity.

From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy

D. Isla, J. Pardo, E. M. Gálvez, 2020, Cancers.

Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

D. Isla, J. Pardo, E. M. Gálvez, 2020, Cells.

Germline TP53 pathogenic variants and breast cancer: A narrative review.

S. Linn, P. Dubsky, A. Partridge, 2023, Cancer treatment reviews.

Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders

O. Díez, E. Tizzano, M. Codina-Solà, 2022, Journal of Medical Genetics.

Association between missense variants of uncertain significance in the CHEK2 gene and hereditary breast cancer: a cosegregation and bioinformatics analysis

J. J. Galano-Frutos, M. Cruellas, H. García-Cebollada, 2024, Frontiers in genetics.

Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancer

J. Paño, M. Cruellas, A. Sesma, 2024, Heliyon.